Meta Platforms (META) Pre‑Market Update Today — November 7, 2025: Reuters scam‑ads bombshell, fresh AI‑training lawsuit, and what it means for the stock

Meta’s AI Revolution Unleashed: July 2025 Breakthroughs, Billion‑Dollar Bets & Backlash

7 November 2025

Before the opening bell on Friday, November 7, 2025, here’s everything traders and long‑term investors need to know about Meta Platforms, Inc. (NASDAQ: META).

META at a glance before the bell (Nov 7, 2025)

Prev. close (Thu, Nov 6):$618.94. ^[1]
Indications pre‑market (venue snapshots): MarketWatch showed $621.20 at 4:16 a.m. ET; Public.com showed $617.40 near 6:00 a.m. ET; MarketChameleon’s consolidated pre‑market print showed $632.01 (indicative; venues differ). Net take: flat to modestly higher versus Thursday’s close, with dispersion by venue and timestamp. ^[2]

What’s new today (Nov 7) that could move META

Reuters investigation: internal papers tie up to 10% of 2024 revenue to scam & prohibited ads
A Reuters investigations report says Meta’s internal documents projected about 10% of 2024 revenue (~$16B) coming from scam or otherwise prohibited advertising, and estimated ~15 billion “higher‑risk” scam ads per day across its apps. Meta disputed the framing, saying the estimate was “rough and overly‑inclusive” and that it has cut scam‑ad reports significantly. Expect regulatory and reputational overhang headlines to linger into today’s session. ^[3]
New copyright lawsuit over AI training
Entrepreneur Media filed suit in California federal court, alleging Meta copied business books and guides to train Llama models and generate competing content. Meta hasn’t commented publicly yet. AI‑IP litigation risk remains an ongoing theme for big models, including at Meta. ^[4]

The bigger backdrop investors are trading against

Q3 2025: strong top line, heavier spend, and a one‑time tax hit
Meta reported $51.24B in revenue (+26% y/y) for Q3; ad impressions rose 14% with +10% average price per ad; family daily active people reached 3.54B. Management guided Q4 revenue to $56–$59B and lifted 2025 capex to $70–$72B to fund AI infrastructure. Results also reflected a non‑cash, one‑time tax charge of ~$15.93B that depressed GAAP EPS—management detailed the charge and noted cash tax payments should be lower going forward. ^[5]
Funding the AI buildout: record bond deal + data‑center JV
On Oct. 30, Meta said it would raise up to $30B in its largest‑ever bond sale (5‑ to 40‑year maturities), explicitly to help fund AI infrastructure. Separately, in October Meta announced a joint venture with Blue Owl to finance and operate the Hyperion data‑center campus in Louisiana. Both moves underscore management’s plan to front‑load compute investment while supported by ad cash flows. ^[6]
Fresh product signals
Yesterday Meta announced it’s bringing “Vibes,” a new AI short‑video feed, to Europe, adding to a cadence of AI‑first product updates likely to feature in engagement and monetization narratives into 2026. ^[7]

Regulatory and legal heat map to keep on the screen

India: Appeals tribunal lifted a five‑year ban on WhatsApp data sharing with Meta entities (while upholding a fine), a partial win as Meta navigates privacy competition scrutiny in a key growth market. ^[8]
France/EU: Meta rejected a French rights watchdog ruling that found elements of Facebook’s job‑ads delivery discriminatory by gender; the case adds to Europe’s broader scrutiny of targeting systems. ^[9]
EU DSA backdrop: Reports last month suggested the European Commission is preparing preliminary findings alleging Meta isn’t adequately policing illegal content under the Digital Services Act, a process that could carry fines up to 6% of global revenue if upheld. ^[10]

Why it matters this morning: today’s Reuters scam‑ads story and the AI‑training suit arrive as regulators already probe Meta’s ad integrity and data practices—raising the probability of incremental compliance costs, product changes (which can affect ad yield), and headline risk into year‑end.

Street positioning and what pros are saying

Post‑earnings recalibration, still broadly positive: After Q3, several firms trimmed targets on spending intensity while staying bullish on ad fundamentals; others raised estimates on engagement and ad tools. For example, UBS lifted its META target to $915 (Buy), while Cantor cut to $830 (Overweight) and DA Davidson reiterated $825 (Buy). Expect the buy‑side debate to center on AI capex timing vs. ad cash‑flow durability. ^[11]

Trading lens for today’s session

Tape setup: With yesterday’s close at $618.94 and pre‑market indications clustered near $617–$621 (venue dispersion up to low‑$630s on isolated prints), META is set for a muted open absent a new catalyst. Liquidity in pre‑market can exaggerate moves; broader futures and mega‑cap tech flows may drive the first hour. ^[12]
Headline risk: Watch for any regulator or company response to Reuters’ investigation; further media amplification can nudge short‑term sentiment. ^[13]
Medium‑term driver: The capex curve (2025–2026) versus ad revenue momentum remains the fulcrum for valuation. Management’s guidance implies notably larger capex in 2026, so investors will keep stress‑testing ROIC on AI/data‑center spend and gauging any bond‑market pricing updates from the $30B raise. ^[14]

Bottom line

For Nov 7, 2025 pre‑market, META’s price indications suggest a quiet open, but the news flow isn’t quiet. A high‑impact Reuters investigation on scam‑ad revenue exposure and a new AI‑copyright suit add non‑fundamental risk to the near‑term narrative, even as the fundamental backdrop remains anchored by double‑digit ad growth, massive user scale, and a multi‑year AI infrastructure sprint. Expect traders to fade early volatility and position around headline cadence, while long‑only investors keep focusing on capex payback, regulatory outcomes, and ad monetization quality into 2026. ^[15]

Sources & further reading

Reuters investigation on scam ads and revenue exposure. ^[16]
Lawsuit: Entrepreneur Media v. Meta (Reuters legal). ^[17]
Meta Q3 2025 earnings press release, KPIs, Q4 guide, 2025 capex. ^[18]
Meta to raise $30B in bonds for AI capex (Reuters). ^[19]
Meta Newsroom: “Bringing Vibes to Europe” and recent product updates. ^[20]
India tribunal ruling on WhatsApp data sharing (Reuters). ^[21]
French rights‑watchdog ruling and Meta’s response (Reuters). ^[22]
Analyst target moves post‑Q3 (Investing.com recap: UBS $915; Cantor $830; DA Davidson $825). ^[23]
Pre‑market indications and prior close: MarketWatch, Public.com, MarketChameleon, Investing.com. ^[24]

Disclosure: This article is for information only and is not investment advice. Markets move quickly; always check live quotes and filings before trading.

5 BEST Stocks to BUY Now (I'M BUYING)

Watch this video on YouTube.

References

1. www.investing.com, 2. www.marketwatch.com, 3. www.reuters.com, 4. www.reuters.com, 5. investor.atmeta.com, 6. www.reuters.com, 7. about.fb.com, 8. www.reuters.com, 9. www.reuters.com, 10. www.reuters.com, 11. www.investing.com, 12. www.investing.com, 13. www.reuters.com, 14. investor.atmeta.com, 15. www.reuters.com, 16. www.reuters.com, 17. www.reuters.com, 18. investor.atmeta.com, 19. www.reuters.com, 20. about.fb.com, 21. www.reuters.com, 22. www.reuters.com, 23. www.investing.com, 24. www.marketwatch.com

Tags:

Marcin Frąckiewicz Latest posts

CEO of TS2 Space and founder of TS2.tech. Expert in satellites, telecommunications, and emerging technologies, covering trends in space, AI, and connectivity.

View all

Strategy Upsizes €620M Stream Preferred Stock Offering to Fund Bitcoin Purchases and Growth
November 7, 2025, 10:28 AM EST. Strategy Inc., founded by billionaire Michael Saylor, has upsized its initial public offering to raise €620 million through the sale of 10% Series A Perpetual Stream Preferred Stock (STRE). The issue covers 7.75 million shares priced at €80 each, with gross proceeds of €620 million and net proceeds reported around €702.2 million after fees. The funds will be used for general corporate purposes, including expanding Bitcoin holdings and supporting growth initiatives. STRE carries a 10% annual dividend, payable quarterly, with a built-in mechanism to compound if payments are missed. Investors also have redemption rights in a fundamental change scenario. The deal highlights Strategy's ongoing commitment to Bitcoin as a treasury asset and its strategy to blend tech finance with cryptocurrency exposure.
MarketAxess (MKTX) Q3 Earnings Beat Estimates; Shares Down YTD
November 7, 2025, 10:26 AM EST. MarketAxess Corporation (MKTX) reported Q3 earnings of $1.84 per share, beating the Zacks Consensus of $1.69 and delivering an +8.88% surprise vs. last year's $1.90. Revenue rose to $208.82 million, topping the consensus by 1.17% and up from $206.71 million a year earlier. In the last four quarters, the company has topped EPS estimates four times. Despite the beat, the stock is down about 26.7% year-to-date, underperforming the S&P 500. Ahead, near-term estimates had been revised unfavorably, contributing to a Zacks Rank #5 (Strong Sell). The current quarter is seen at $1.75 per share on $214.94 million in revenue, with the full year at $7.24 on $852.89 million. Investors will parse management commentary for clarity on the outlook.
Piper Sandler Cuts Figma Target, Signals 59% Upside Amid Mixed Analyst Notes
November 7, 2025, 10:24 AM EST. Analysts at Piper Sandler cut their FIG price target from $85 to $70, while keeping an overweight rating and implying about a 59.3% upside. Figma has drawn mixed notes from others: RBC trimmed to $65 with a sector perform tag; Bank of America to $69 with a buy rating; Goldman Sachs initiated coverage at neutral with a $48 target; Wells Fargo at $52 with equal weight. Market consensus remains Hold per MarketBeat, with an average target around $62.71. The shares opened near $43.94; the year's range spans about $43.80 to $142.92. For the latest quarter, EPS was -$0.07 vs est $0.08, and revenue was $249.64M vs est $248.97M. Notable insider trades were disclosed by General Counsel Brendan Mulligan and CRO Shaunt Voskanian.
Sanuwave Health (SNWV) Q3 Beats on EPS and Revenue; Zacks Rank Holds
November 7, 2025, 10:22 AM EST. Sanuwave Health reported Q3 EPS of $0.46, beating the Zacks Consensus Estimate of $0.32 by +43.75%. The company swung from a year-ago loss of $6.49 per share (adjusted for non-recurring items). Revenue came in at $11.45 million, topping the consensus by 0.18% and up from $9.36 million a year earlier. YTD, shares are up about 14.8%, modestly ahead of the S&P 500's 14.3%. The stock carries a Zacks Rank #3 (Hold) as earnings estimate revisions are mixed ahead of the next-quarter and full-year outlook. For the coming quarter, current consensus is $0.20 on $13.5 million in revenue, and for the full year $0.34 on $44.44 million in revenue. Industry wise, Medical - Products remains in the bottom 35% of its group.
Hain Celestial Q3 Revenue Beat but Organic Decline and Margin Pressure
November 7, 2025, 10:20 AM EST. Hain Celestial (HAIN) reported Q3 CY2025 revenue of $367.9 million, beating estimates by 2.1%, but still down 6.8% YoY. The company posted Adjusted EPS of -$0.08, a 48.1% miss vs consensus of -$0.05. Adjusted EBITDA came in at $19.73 million, with a 5.4% EBITDA margin and an operating margin of -1.9%, vs 2.1% last year. Free cash flow was - $13.71 million. Organic revenue declined about 6% YoY, signaling demand weakness despite a modest beat to some estimates. Market cap sits near $96.6 million. Management highlighted cost discipline and progress on the plan with five actions to win. With roughly $1.53 billion in trailing revenue, investors will weigh whether organic growth can reaccelerate to support margins and a sustainable path forward.